Professor | Jiaming Lan | Asia Growth Partners

Name	Jiaming Lan
Contact Information	jmlan@ips.ac.cn
Language ability	Chinese, English
Province	Shanghai

Name

Jiaming Lan

Contact Information

jmlan@ips.ac.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	University of Chinese Academy of Sciences
Faculty	Medical School
Academic Background & Achievements	2013-09 to 2016-07 PhD: Chinese Center for Disease Control and Prevention 2004-09 to 2007-07 Master's: Hebei Medical University 1999-09 to 2004-07 Bachelor's: Hebei Medical University
Work Experience	2023-10 to present - Chinese Academy of Sciences Shanghai Institute of Immunology and Infection - Researcher 2019-03 to 2023-09 - Chinese Academy of Sciences Shanghai Institute of Immunology and Infection (formerly Shanghai Pasteur Institute) - Associate Researcher 2014-12 to 2019-03 - Hebei Medical University - Associate Professor 2013-09 to 2016-07 - Chinese Center for Disease Control and Prevention - PhD Student 2009-12 to 2014-12 - Hebei Medical University - Lecturer 2007-07 to 2009-12 - Hebei Medical University - Assistant Lecturer
Awards	CVB3 Vaccine Series Research (2012): Third Prize, Municipal Level

University/Lab Affiliation and Title

University of Chinese Academy of Sciences

Faculty

Medical School

Academic Background & Achievements

2013-09 to 2016-07 PhD: Chinese Center for Disease Control and Prevention
2004-09 to 2007-07 Master's: Hebei Medical University
1999-09 to 2004-07 Bachelor's: Hebei Medical University

Work Experience

2023-10 to present - Chinese Academy of Sciences Shanghai Institute of Immunology and Infection - Researcher
2019-03 to 2023-09 - Chinese Academy of Sciences Shanghai Institute of Immunology and Infection (formerly Shanghai Pasteur Institute) - Associate Researcher
2014-12 to 2019-03 - Hebei Medical University - Associate Professor
2013-09 to 2016-07 - Chinese Center for Disease Control and Prevention - PhD Student
2009-12 to 2014-12 - Hebei Medical University - Lecturer
2007-07 to 2009-12 - Hebei Medical University - Assistant Lecturer

Awards

CVB3 Vaccine Series Research (2012): Third Prize, Municipal Level

Areas of Focus	Viral Vaccines Therapeutic Antibodies Antiviral Drugs
Publications	Extracellular Disintegration of Viral Proteins as an Innovative Strategy for Developing Broad-Spectrum Antivirals Against Coronavirus, Jiaming Lan, 2024 Both chimpanzee adenovirus-based and DNA vaccines induced long-term immunity and conferred complete protection against Nipah virus infection, Jiaming Lan, 2023 Vaccines based on the fusion protein consensus sequence protect Syrian hamsters from Nipah virus infection, Jiaming Lan, 2023 Recombinant Chimpanzee Adenovirus Vector Vaccine Expressing the Spike Protein Provides Effective and Lasting Protection against SARS-CoV-2 Infection, Jiaming Lan, 2022 Design of Replication-Competent VSV- and Ervebo-Vectored Vaccines Against SARS-CoV-2, Jiaming Lan, 2022 A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection, Jiaming Lan, 2021 Clinical and Laboratory-Derived Parameters of 119 Hospitalized Patients with Coronavirus Disease 2019 in Xiangyang, Hubei Province, China., Jiaming Lan, 2020 Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections, Jiaming Lan, 2020 Progress on Research Tools of Coronaviruses, Jiaming Lan, 2020 Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression, Jiaming Lan, 2020 Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus, Jiaming Lan, 2018 Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus, Jiaming Lan, 2018 The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection, Jiaming Lan, 2017 Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8(+) T Cell Epitopes and Host MHC, Jiaming Lan, 2017 Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge, Jiaming Lan, 2015 Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen, Jiaming Lan, 2014 Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination, Jiaming Lan, 2011

Areas of Focus

Viral Vaccines
Therapeutic Antibodies
Antiviral Drugs

Publications

Extracellular Disintegration of Viral Proteins as an Innovative Strategy for Developing Broad-Spectrum Antivirals Against Coronavirus, Jiaming Lan, 2024
Both chimpanzee adenovirus-based and DNA vaccines induced long-term immunity and conferred complete protection against Nipah virus infection, Jiaming Lan, 2023
Vaccines based on the fusion protein consensus sequence protect Syrian hamsters from Nipah virus infection, Jiaming Lan, 2023
Recombinant Chimpanzee Adenovirus Vector Vaccine Expressing the Spike Protein Provides Effective and Lasting Protection against SARS-CoV-2 Infection, Jiaming Lan, 2022
Design of Replication-Competent VSV- and Ervebo-Vectored Vaccines Against SARS-CoV-2, Jiaming Lan, 2022
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection, Jiaming Lan, 2021
Clinical and Laboratory-Derived Parameters of 119 Hospitalized Patients with Coronavirus Disease 2019 in Xiangyang, Hubei Province, China., Jiaming Lan, 2020
Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections, Jiaming Lan, 2020
Progress on Research Tools of Coronaviruses, Jiaming Lan, 2020
Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression, Jiaming Lan, 2020
Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus, Jiaming Lan, 2018
Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus, Jiaming Lan, 2018
The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection, Jiaming Lan, 2017
Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8(+) T Cell Epitopes and Host MHC, Jiaming Lan, 2017
Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge, Jiaming Lan, 2015
Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen, Jiaming Lan, 2014
Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination, Jiaming Lan, 2011

Vaccine Virus Immunology Therapeutic Antibody Drug Antiviral Research Development Infection

Rui Gong - University of Chinese Academy of Sciences

Lanping Ma - University of Chinese Academy of Sciences

Lian Huan - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us